文献速递血栓与止血

低风险静脉血栓栓塞症的家庭与医院治疗:系统评价与荟萃分析

Home vs hospital treatment of low-risk venous thromboembolism: a systematic review and meta-analysis.
PubMed 文献 · Blood Adv · 2020-01-01

本系统评价与荟萃分析纳入7项RCT(1922例DVT患者)和2项RCT(445例PE患者)及3项前瞻性队列研究(234例PE患者),比较家庭与医院治疗低风险DVT或PE的安全性和有效性。结果显示家庭治疗DVT可降低PE风险(RR=0.64)和复发性DVT风险(RR=0.61),但死亡和大出血无显著差异;低风险PE的家庭与医院治疗差异存在重要不确定性。

要点

  • 低风险DVT患者家庭治疗可降低PE和复发性DVT风险,证据确定性中等。
  • 低风险PE患者家庭与医院治疗在全因死亡、复发性PE和大出血方面无显著差异,证据确定性低。
  • 低风险DVT患者家庭治疗的患者重要结局风险相似或更低。

核心结论

  • 低风险DVT患者家庭治疗相比医院治疗,患者重要结局风险相似或更低。
  • 低风险PE患者家庭与医院治疗差异存在重要不确定性。

研究设计与样本

  • 系统评价与荟萃分析,检索Medline、Embase和Cochrane数据库至2019年7月,纳入RCT和前瞻性队列研究。
  • 7项RCT(1922例DVT患者)纳入DVT荟萃分析;2项RCT(445例PE患者)和3项前瞻性队列研究(234例PE患者)纳入PE分析。

主要发现

  • DVT家庭治疗降低PE风险(RR=0.64;95%CI 0.44-0.93)和复发性DVT风险(RR=0.61;95%CI 0.42-0.90),证据确定性中等。
  • DVT家庭治疗对死亡和大出血的降低不显著,证据确定性低。
  • 低风险PE家庭治疗在全因死亡、复发性PE和大出血方面无显著差异,证据确定性低。
  • 3项前瞻性队列研究(234例PE患者)的汇总结果相似。

临床怎么用

  • 低风险DVT患者可考虑家庭治疗,因可降低PE和复发性DVT风险。
  • 低风险PE患者家庭治疗与医院治疗差异不确定,需个体化决策。

局限性

  • 低风险PE的结论基于低确定性证据,存在重要不确定性。
  • 纳入研究数量有限,尤其PE的RCT仅2项。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Increasing evidence supports the safety and effectiveness of managing low-risk deep vein thrombosis (DVT) or pulmonary embolism (PE) in outpatient settings. We performed a systematic review to assess safety and effectiveness of managing patients with DVT or PE at home compared with the hospital. Medline, Embase, and Cochrane databases were searched up to July 2019 for relevant randomized clinical trials (RCTs), and prospective cohort studies. Two investigators independently screened titles and abstracts of identified citations and extracted data from relevant full-text papers. Risk ratios (RRs) were calculated, and certainty of evidence was assessed using Grading of Recommendations Assessment, Development and Evaluation (GRADE). Seven RCTs (1922 patients) were included in meta-analyses on managing patients with DVT. Pooled estimates indicated decreased risk of PE (RR = 0.64; 95% confidence interval [CI], 0.44-0.93) and recurrent DVT (RR = 0.61; 95% CI, 0.42-0.90) for home management, both with moderate certainty of the evidence. Reductions in mortality and major bleeding were not significant, both with low certainty of the evidence. Two RCTs (445 patients) were included in meta-analyses on home management of low-risk patients with PE. Pooled estimates indicated no significant difference in all-cause mortality, recurrent PE, and major bleeding, all with low certainty of the evidence. Results of pooled estimates from 3 prospective cohort studies (234 patients) on home management of PE showed similar results. Our findings indicate that low-risk DVT patients had similar or lower risk of patient-important outcomes with home treatment compared with hospital treatment. In patients with low-risk PE, there was important uncertainty about a difference between home and hospital treatment.

来源:Blood Adv,查看原文。版权归原作者所有。

引用

  1. Khatib R, Ross S, Kennedy SA, et al. Home vs hospital treatment of low-risk venous thromboembolism: a systematic review and meta-analysis. Blood Adv. 2020. PMID: 32040553. doi:10.1182/bloodadvances.2019001223

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。